Aptus Pharma shareholders approved two resolutions via postal ballot: increasing authorized share capital and issuing bonus shares in a 3:2 ratio.
All resolutions passed unanimously with 100% votes in favor from both promoter (5 million shares) and public (122,000 shares) shareholders who voted.
The remote e-voting process was conducted from March 27 to April 25, 2026, with CDSL as the voting platform and Mr. Nalin Ganatra as scrutinizer.
The resolutions are deemed approved on April 25, 2026, with the company having 337 shareholders on the record date of March 24, 2026.